Literature DB >> 19157891

The 18q deletion syndrome and analysis of the critical region for orofacial cleft at 18q22.3.

Ales Dostal1, Jitka Nemeckova, Renate Gaillyova.   

Abstract

INTRODUCTION: The 18q deletion syndrome (18q-) is a multiple-anomaly disorder associated with mental retardation, white matter anomalies in the brain, growth hormone deficiency, congenital aural atresia, orofacial cleft (OFC), and palate abnormalities. The aims of this study were to determine the frequency of different forms of OFC in 18q- individuals: cleft palate with or without cleft lip (CP/L), cleft lip (CL), and palate abnormalities. We also sought to map a potential critical region for OFC within chromosome 18q22.3 region. PATIENTS: The study presents an overview of selected 18q- individuals from 11 published reports and one presented poster.
RESULTS: The frequency of CP/L and CL among 18q- individuals is about 25%; when high/arched palate cases are included, the frequency rises to about 43%.
CONCLUSION: Orofacial abnormalities are characteristic features of 18q- syndrome patients and potential CP/L critical region could be assumed at 18q22.3 between markers D18S879 and D18S1141. In addition, gene deficient mouse models for Sall3 or Tshz1 genes, which are located at the 18q22.3 critical region, displayed palate abnormality phenotype.

Entities:  

Mesh:

Year:  2009        PMID: 19157891     DOI: 10.1016/j.jcms.2008.12.002

Source DB:  PubMed          Journal:  J Craniomaxillofac Surg        ISSN: 1010-5182            Impact factor:   2.078


  8 in total

1.  Aberrant methylation and downregulation of sall3 in human hepatocellular carcinoma.

Authors:  Xue-Xi Yang; Jing-Zhe Sun; Fen-Xia Li; Ying-Song Wu; Hong-Yan Du; Wei Zhu; Xiang-Hong Li; Ming Li
Journal:  World J Gastroenterol       Date:  2012-06-07       Impact factor: 5.742

2.  Rare and frequent promoter methylation, respectively, of TSHZ2 and 3 genes that are both downregulated in expression in breast and prostate cancers.

Authors:  Miyako Yamamoto; Emili Cid; Samuel Bru; Fumiichiro Yamamoto
Journal:  PLoS One       Date:  2011-03-14       Impact factor: 3.240

Review 3.  Central hypogonadotropic hypogonadism: genetic complexity of a complex disease.

Authors:  Marco Marino; Valeria Moriondo; Eleonora Vighi; Elisa Pignatti; Manuela Simoni
Journal:  Int J Endocrinol       Date:  2014-09-01       Impact factor: 3.257

4.  Epigenetic silencing of SALL3 is an independent predictor of poor survival in head and neck cancer.

Authors:  Kiyoshi Misawa; Daiki Mochizuki; Atsushi Imai; Yuki Misawa; Shiori Endo; Masato Mima; Hideya Kawasaki; Thomas E Carey; Takeharu Kanazawa
Journal:  Clin Epigenetics       Date:  2017-06-12       Impact factor: 6.551

Review 5.  Chromosome 18q-syndrome and 1p terminal duplication in a patient with bilateral vesico-ureteral reflux: case report and literature revision.

Authors:  Elisa Brandigi; Francesco Molinaro; Anna Lavinia Bulotta; Rossella Angotti; Maria Pavone; Mario Messina
Journal:  Ital J Pediatr       Date:  2013-01-23       Impact factor: 2.638

6.  Systematic analysis of copy number variants of a large cohort of orofacial cleft patients identifies candidate genes for orofacial clefts.

Authors:  Federica Conte; Martin Oti; Jill Dixon; Carine E L Carels; Michele Rubini; Huiqing Zhou
Journal:  Hum Genet       Date:  2015-11-11       Impact factor: 4.132

Review 7.  SALL Proteins; Common and Antagonistic Roles in Cancer.

Authors:  Claudia Álvarez; Aracelly Quiroz; Diego Benítez-Riquelme; Elizabeth Riffo; Ariel F Castro; Roxana Pincheira
Journal:  Cancers (Basel)       Date:  2021-12-15       Impact factor: 6.639

Review 8.  Clinical Characteristics and Long-Term Recombinant Human Growth Hormone Treatment of 18q- Syndrome: A Case Report and Literature Review.

Authors:  Shanshan Liu; Meiping Chen; Hongbo Yang; Shi Chen; Linjie Wang; Lian Duan; Huijuan Zhu; Hui Pan
Journal:  Front Endocrinol (Lausanne)       Date:  2021-12-09       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.